HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Hydralazine Hydrochloride And Hydrochlorothiazide patents expire, and what generic alternatives are available?
Hydralazine Hydrochloride And Hydrochlorothiazide is a drug marketed by Solvay, Superpharm, and Watson Labs. and is included in eight NDAs.
The generic ingredient in HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What are the global sales for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
Summary for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 3 |
DailyMed Link: | HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Center for Research Resources (NCRR) | Phase 4 |
Vanderbilt University Medical Center | Phase 4 |
Vanderbilt University Medical Center | Phase 1 |
See all HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE clinical trials